Increased local levels of granulocyte colony-stimulating factor are associated with the beneficial effect of pre-elafin (SKALP/trappin-2/WAP3) in experimental emphysema
-
Marie France Janelle
Abstract
Few therapeutic options are offered to treat inflammation and alveolar wall destruction in emphysema. The effect of recombinant human pre-elafin, an elastase inhibitor, was evaluated in porcine pancreatic elastase (PPE)-induced emphysema in C57BL/6 mice. In a first protocol, mice received a single instillation of pre-elafin (17.5 pmol/mouse) at 1 h post-PPE and were sacrificed up to 72 h post-PPE. A single instillation of pre-elafin significantly reduced PPE-induced neutrophil accumulation in lungs, as assessed by bronchoalveolar lavage (BAL), by 51%, 71% and 67% at 24, 48 and 72 h, respectively. In a second protocol, mice also received a single dose of PPE, but pre-elafin three times a week for 2 weeks. After 2 weeks, pre-elafin significantly reduced the PPE-induced increase in BAL macrophage numbers, airspace dimensions and lung hysteresivity by 74%, 62% and 52%, respectively. Since G-CSF was previously shown to reduce emphysematous changes in mice, the BAL levels of this mediator were measured 6 h post-PPE in animals treated as described in the first protocol. Pre-elafin significantly increased G-CSF levels in PPE-exposed mice compared to sham- and PPE only-exposed animals. This suggests that the beneficial effects of pre-elafin could be mediated, at least in part, by its ability to increase G-CSF levels in the lung.
References
Barnes, P.J. (2003). New concepts in chronic obstructive pulmonary disease. Annu. Rev. Med.54, 113–129.10.1146/annurev.med.54.101601.152209Search in Google Scholar
Barnes, P.J. (2004a). Alveolar macrophages in chronic obstructive pulmonary disease (COPD). Cell. Mol. Biol. (Noisy-le-grand) 50 Online Publication, OL627–OL637.Search in Google Scholar
Barnes, P.J. (2004b). COPD: is there light at the end of the tunnel? Curr. Opin. Pharmacol.4, 263–272.10.1016/j.coph.2004.03.001Search in Google Scholar
Barnes, P.J. (2004c). Mediators of chronic obstructive pulmonary disease. Pharmacol. Rev.56, 515–548.10.1124/pr.56.4.2Search in Google Scholar
Bingle, L., Tetley, T.D., and Bingle, C.D. (2001). Cytokine-mediated induction of the human elafin gene in pulmonary epithelial cells is regulated by nuclear factor-κB. Am. J. Respir. Cell Mol. Biol.25, 84–91.10.1165/ajrcmb.25.1.4341Search in Google Scholar
Boneberg, E.-M. and Hartung, T. (2002). Molecular aspects of anti-inflammatory action of G-CSF. Inflamm. Res.51, 119–128.10.1007/PL00000283Search in Google Scholar
Bourbonnais, Y., Larouche, C., and Tremblay, G.M. (2000). Production of full-length human pre-elafin, an elastase specific inhibitor, from yeast requires the absence of a functional Yapsin 1 (Yps1p) endoprotease. Protein Expr. Purif.20, 485–491.10.1006/prep.2000.1338Search in Google Scholar
Calverley, P.M.A. and Walker, P. (2003). Chronic obstructive pulmonary disease. Lancet362, 1053–1061.10.1016/S0140-6736(03)14416-9Search in Google Scholar
Donnelly, L.E. and Rogers, D.F. (2003). Therapy for chronic obstructive pulmonary disease in the 21st century. Drugs63, 1973–1998.10.2165/00003495-200363190-00002Search in Google Scholar PubMed
Dunnill, M.S. (1962). Quantitative methods in the study of pulmonary pathology. Thorax17, 320–328.10.1136/thx.17.4.320Search in Google Scholar PubMed PubMed Central
El Ouriaghli, F., Fujiwara, H., Melenhorst, J.J., Sconocchia, G., Hensel, N., and Barrett, A.J. (2003). Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesis. Blood101, 1752–1758.10.1182/blood-2002-06-1734Search in Google Scholar PubMed
Hareng, L. and Hartung, T. (2002). Induction and regulation of endogenous granulocyte colony-stimulating factor formation. Biol. Chem.383, 1501–1517.10.1515/BC.2002.172Search in Google Scholar
Hirche, T.O., Atkinson, J.J., Bahr, S., and Belaaouaj, A. (2004). Deficiency in neutrophil elastase does not impair neutrophil recruitment to inflamed sites. Am. J. Respir. Cell Mol. Biol.30, 576–584.10.1165/rcmb.2003-0253OCSearch in Google Scholar
Ishizawa, K., Kubo, H., Yamada, M., Kobayashi, S., Numasaki, M., Ueda, S., Suzuki, T., and Sasaki, H. (2004). Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett.556, 249–252.10.1016/S0014-5793(03)01399-1Search in Google Scholar
Ito, S., Ingenito, E.P., Brewer, K.K., Black, L.D., Parameswaran, H., Lutchen, K.R., and Suki, B. (2005). Mechanics, nonlinearity, and failure strength of lung tissue in a mouse model of emphysema: possible role of collagen remodeling. J. Appl. Physiol.98, 503–511.10.1152/japplphysiol.00590.2004Search in Google Scholar PubMed
Jian, M.-Y., Koizumi, T., Tsushima, K., Fujimoto, K., and Kubo, K. (2004). Effects of granulocyte colony-stimulating factor (G-CSF) and neutrophil elastase inhibitor (ONO-5046) on acid-induced lung injury in rats. Inflammation28, 327–336.10.1007/s10753-004-6643-xSearch in Google Scholar PubMed
Koyama, S., Sato, E., Masubuchi, T., Takamizawa, A., Kubo, K., Nagai, S., and Izumi, T. (1998). Alveolar type II-like cells release G-CSF as neutrophil chemotactic activity. Am. J. Physiol.275, L687–L693.10.1152/ajplung.1998.275.4.L687Search in Google Scholar PubMed
Kuraki, T., Ishibashi, M., Takayama, M., Shiraishi, M., and Yoshida, M. (2002). A novel oral neutrophil elastase inhibitor (ONO-6818) inhibits human neutrophil elastase-induced emphysema in rats. Am. J. Respir. Crit. Care Med.166, 496–500.10.1164/rccm.2103118Search in Google Scholar PubMed
Lucey, E.C., Keane, J., Kuang, P.-P., Snider, G.L., and Goldstein, R.H. (2002). Severity of elastase-induced emphysema is decreased in tumor necrosis factor-α and interleukin-1β receptor-deficient mice. Lab. Invest.82, 79–85.10.1038/labinvest.3780397Search in Google Scholar PubMed
Lundblad, L.K.A., Thompson-Figueroa, J., Leclair, T., Sullivan, M.J., Poynter, M.E., Irvin, C.G., and Bates, J.H.T. (2005). Tumor necrosis factor-α overexpression in lung disease: a single cause behind a complex phenotype. Am. J. Respir. Crit. Care Med.171, 1363–1370.10.1164/rccm.200410-1349OCSearch in Google Scholar PubMed PubMed Central
Lyerla, T.A., Rusiniak, M.E., Borchers, M., Jahreis, G., Tan, J., Ohtake, P., Novak, E.K., and Swank, R.T. (2003). Aberrant lung structure, composition, and function in a murine model of Hermansky-Pudlak syndrome. Am. J. Physiol.285, L643–L653.10.1152/ajplung.00024.2003Search in Google Scholar PubMed
Molhuizen, H.O.F. and Schalkwijk, J. (1995). Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI. Biol. Chem. Hoppe-Seyler376, 1–7.Search in Google Scholar
Nara, K., Ito, S., Ito, T., Suzuki, Y., Ghoneim, M.A., Tachibana, S., and Hirose, S. (1994). Elastase inhibitor elafin is a new type of a proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed ‘cementoin’. J. Biochem.115, 441–448.10.1093/oxfordjournals.jbchem.a124357Search in Google Scholar
Nénan, S., Boichot, E., Lagente, V., and Bertrand, C.P. (2005). Macrophage elastase (MMP-12): a pro-inflammatory mediator? Mem. Inst. Oswaldo Cruz100 (Suppl. 1), 167–172.10.1590/S0074-02762005000900028Search in Google Scholar
Ohta, K., Nakajima, T., Cheah, A.Y.L., Zaidi, S.H.E., Kaviani, N., Dawood, F., You, X.-M., Liu, P., Husain, M., and Rabinovitch, M. (2004). Elafin-overexpressing mice have improved cardiac function after myocardial infarction. Am. J. Physiol.287, H286–H292.10.1152/ajpheart.00479.2002Search in Google Scholar
Sakai, H., Ingenito, E.P., Mora, R., Abbay, S., Cavalcante, F.S.A., Lutchen, K.R., and Suki, B. (2001). Hysteresivity of the lung and tissue strip in the normal rat: effects of heterogeneities. J. Appl. Physiol.91, 737–747.10.1152/jappl.2001.91.2.737Search in Google Scholar
Sano, C., Shimizu, T., Sato, K., Kawauchi, H., and Tomioka, H. (2000). Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-β (TGF-β), by lipopolysaccharide-stimulated macrophages. Clin. Exp. Immunol.121, 77–85.Search in Google Scholar
Schalkwijk, J., Wiedow, O., and Hirose, S. (1999). The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochem. J.340, 569–577.10.1042/bj3400569Search in Google Scholar
Schuessler, T.F. and Bates, J.H.T. (1995). A computer-controlled research ventilator for small animals: design and evaluation. IEEE Trans. Biomed. Eng.42, 860–866.10.1109/10.412653Search in Google Scholar
Shapiro, S.D. (2005). COPD unwound. N. Engl. J. Med.352, 2016–2019.10.1056/NEJMe058044Search in Google Scholar
Shapiro, S.D., Goldstein, N.M., Houghton, A.M., Kobayashi, D.K., Kelley, D., and Belaaouaj, A. (2003). Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am. J. Pathol.163, 2329–2335.10.1016/S0002-9440(10)63589-4Search in Google Scholar
Soskel, N.T., Watanabe, S., Hardie, R., Shenvi, A.B., Punt, J.A., and Kettner, C. (1986). Effects of dosage and timing of administration of a peptide boronic acid inhibitor on lung mechanics and morphometrics in elastase-induced emphysema in hamsters. Am. Rev. Respir. Dis.133, 635–638.Search in Google Scholar
Spurzem, J.R. and Rennard, S.I. (2005). Pathogenesis of COPD. Sem. Respir. Crit. Care Med.26, 142–153.10.1055/s-2005-869535Search in Google Scholar PubMed
Steel, R.G.D. and Torrie, J.H. (1980). Principles and Procedures of Statistics. A Biometrical Approach (New York, USA: McGraw-Hill).Search in Google Scholar
Stockley, R.A. (2002). Neutrophils and the pathogenesis of COPD. Chest121, 151S–155S.10.1378/chest.121.5_suppl.151SSearch in Google Scholar PubMed
Stolk, J., Rudolphus, A., Davies, P., Osinga, D., Dijkman, J.H., Agarwal, L., Keenan, K.P., Fletcher, D., and Kramps, J.A. (1992). Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster. J. Pathol.167, 349–356.10.1002/path.1711670314Search in Google Scholar
Tanaka, H., Nishino, M., Nakamori, Y., Ogura, H., Ishikawa, K., Shimazu, T., and Sugimoto, H. (2001). Granulocyte colony-stimulating factor (G-CSF) stiffens leukocytes but attenuates inflammatory response without lung injury in septic patients. J. Trauma51, 1110–1116.10.1097/00005373-200112000-00016Search in Google Scholar
Tazi, A., Nioche, S., Chastre, J., Smiéjan, J.-M., and Hance, A.J. (1991). Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage. Am. J. Respir. Cell Mol. Biol.4, 140–147.10.1165/ajrcmb/4.2.140Search in Google Scholar
Tessier, P.A., Naccache, P.H., Diener, K.R., Gladue, R.P., Neote, K.S., Clark-Lewis, I., and McColl, S.R. (1998). Induction of acute inflammation in vivo by staphylococcal superantigens. II. Critical role for chemokines, ICAM-1, and TNF-α. J. Immunol.161, 1204–1211.Search in Google Scholar
Thébaud, B., Dansereau, A., Ladha, F., Bonnet, S., Sawicka, M., Bourbonnais, Y., Eaton, F., and Tremblay, G. (2005). Pre-elafin, a natural elastase inhibitor, prevents oxygen-induced lung injury in experimental bronchopulmonary dysplasia (BPD) [Abstract]. Proc. Am. Thorac. Soc.2, A24.Search in Google Scholar
Tremblay, G.M., Vachon, E., Larouche, C., and Bourbonnais, Y. (2002). Inhibition of human neutrophil elastase-induced acute lung injury in hamsters by recombinant human pre-elafin (trappin-2). Chest121, 582–588.10.1378/chest.121.2.582Search in Google Scholar
Tremblay, G.M., Janelle, M.F., and Bourbonnais, Y. (2003). Anti-inflammatory activity of neutrophil elastase inhibitors. Curr. Opin. Invest. Drugs4, 556–565.Search in Google Scholar
Tuder, R.M., McGrath, S., and Neptune, E. (2003). The pathobiological mechanisms of emphysema models: what do they have in common? Pulm. Pharmacol. Ther.16, 67–78.10.1016/S1094-5539(02)00099-8Search in Google Scholar
Vachon, E., Bourbonnais, Y., Bingle, C.D., Rowe, S.J., Janelle, M.F., and Tremblay, G.M. (2002). Anti-inflammatory effect of pre-elafin in lipopolysaccharide-induced acute lung inflammation. Biol. Chem.383, 1249–1256.10.1515/BC.2002.138Search in Google Scholar PubMed
Van de Kerkhof, P.C.M., Kuppens, L.H.C.M., Van Vlijmen, Y., and Schalkwijk, J. (1991). Distribution of skin-derived antileucoproteases (SKALP) in the marginal zone of the spreading psoriatic lesion. Br. J. Dermatol.124, 10–12.10.1111/j.1365-2133.1991.tb03275.xSearch in Google Scholar PubMed
van Eeden, S.F., Lawrence, E., Sato, Y., Kitagawa, Y., and Hogg, J.C. (2000). Neutrophils released from the bone marrow by granulocyte colony-stimulating factor sequester in lung microvessels but are slow to migrate. Eur. Respir. J.15, 1079–1086.10.1034/j.1399-3003.2000.01516.xSearch in Google Scholar PubMed
Zaidi, S.H.E., You, X.-M., Ciura, S., O'Blenes, S., Husain, M., and Rabinovitch, M. (2000). Suppressed smooth muscle proliferation and inflammatory cell invasion after arterial injury in elafin-overexpressing mice. J. Clin. Invest.105, 1687–1695.10.1172/JCI9147Search in Google Scholar PubMed PubMed Central
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- 4th General Meeting of the International Proteolysis Society/International Conference on Protease Inhibitors
- Extracellular granzymes: current perspectives
- Impact of the N-terminal amino acid on targeted protein degradation
- Structural aspects of recently discovered viral deubiquitinating activities
- Cysteine cathepsins and caspases in silicosis
- The proprotein convertases and their implication in sterol and/or lipid metabolism
- PREPL: a putative novel oligopeptidase propelled into the limelight
- Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice
- Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases
- Increased local levels of granulocyte colony-stimulating factor are associated with the beneficial effect of pre-elafin (SKALP/trappin-2/WAP3) in experimental emphysema
- Interaction of a novel form of Pseudomonas aeruginosa alkaline protease (aeruginolysin) with interleukin-6 and interleukin-8
- Analysis of aldosterone-induced differential receptor-independent protein patterns using 2D-electrophoresis and mass spectrometry
- Modeling the 3D structure of wheat subtilisin/chymotrypsin inhibitor (WSCI). Probing the reactive site with two susceptible proteinases by time-course analysis and molecular dynamics simulations
- A stable analogue of glucose-dependent insulinotropic polypeptide, GIP(LysPAL16), enhances functional differentiation of mouse embryonic stem cells into cells expressing islet-specific genes and hormones
- Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4
- Despite its strong transactivation domain, transcription factor FOXM1c is kept almost inactive by two different inhibitory domains
- Inhibition of calcineurin by infusion of CsA causes hyperphosphorylation of tau and is accompanied by abnormal behavior in mice
- Isolation and properties of extracellular proteinases of Penicillium marneffei
- Isolation and comparative characterization of Ki-67 equivalent antibodies from the HuCAL® phage display library
Articles in the same Issue
- 4th General Meeting of the International Proteolysis Society/International Conference on Protease Inhibitors
- Extracellular granzymes: current perspectives
- Impact of the N-terminal amino acid on targeted protein degradation
- Structural aspects of recently discovered viral deubiquitinating activities
- Cysteine cathepsins and caspases in silicosis
- The proprotein convertases and their implication in sterol and/or lipid metabolism
- PREPL: a putative novel oligopeptidase propelled into the limelight
- Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice
- Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases
- Increased local levels of granulocyte colony-stimulating factor are associated with the beneficial effect of pre-elafin (SKALP/trappin-2/WAP3) in experimental emphysema
- Interaction of a novel form of Pseudomonas aeruginosa alkaline protease (aeruginolysin) with interleukin-6 and interleukin-8
- Analysis of aldosterone-induced differential receptor-independent protein patterns using 2D-electrophoresis and mass spectrometry
- Modeling the 3D structure of wheat subtilisin/chymotrypsin inhibitor (WSCI). Probing the reactive site with two susceptible proteinases by time-course analysis and molecular dynamics simulations
- A stable analogue of glucose-dependent insulinotropic polypeptide, GIP(LysPAL16), enhances functional differentiation of mouse embryonic stem cells into cells expressing islet-specific genes and hormones
- Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4
- Despite its strong transactivation domain, transcription factor FOXM1c is kept almost inactive by two different inhibitory domains
- Inhibition of calcineurin by infusion of CsA causes hyperphosphorylation of tau and is accompanied by abnormal behavior in mice
- Isolation and properties of extracellular proteinases of Penicillium marneffei
- Isolation and comparative characterization of Ki-67 equivalent antibodies from the HuCAL® phage display library